FDA-Approved HRT Medication List 2026: Pills, Patches, Gels, Creams, Rings — and What Each One Treats

Best for you if / Not for you if

Start here: which need points to which medication

What’s on the FDA-approved HRT medication list in 2026?

FDA-approved menopause hormone therapy falls into four main groups: systemic estrogen alone, estrogen combined with a progestogen, progestogen alone, and low-dose vaginal estrogen — plus a combined estrogen-and-SERM option. The right group for any woman depends on her symptoms, whether she has a uterus, her health history, and her medication route preference. In 2026, the FDA also updated the warning labels on these products.

Two quick terms, because they clear up most of the confusion:

• Systemic means the hormone travels through your whole body. This is what treats hot flashes and night sweats (doctors call these vasomotor symptoms, or VMS).
• Local(or vaginal) means the hormone mostly stays where you put it. This treats vaginal dryness and painful sex — now called genitourinary syndrome of menopause, or GSM — but won’t do much for hot flashes.

The 2026 FDA-Approved Menopause HRT Route & Decision Matrix

Last verified July 2026. Specific milligram doses are set on the label and by your clinician — not by a website. Some older brand names may be discontinued or available only as generics; confirm any specific product using Drugs@FDA or your pharmacy.

Older and less common FDA-approved products (verify availability)

The FDA’s list also includes some products you’ll see less often for menopause today — and some legacy brand names that may be discontinued or sold only as generics now.

• Estrogen injections: estradiol valerate (Delestrogen) and estradiol cypionate (Depo-Estradiol). Given by injection; used less often for everyday menopause symptoms than pills, patches, or gels.
• Older or less common oral and patch names: Menest (esterified estrogens), Femtrace (estradiol acetate), Ogen and Ortho-Est (estropipate), and older estradiol patches such as Estraderm and Vivelle.
• Discontinued or limited-availability products come and go. Two minutes in Drugs@FDA settles whether a product is still on the shelf.

The distinction that trips everyone up: ingredient vs. finished drug

Take estradiol. Estradiol shows up in FDA-approved products like the Climara patch and Estrace pills. That same estradiol also shows up in compounded creams mixed at a pharmacy. Same hormone. Completely different regulatory status.

A finished drugis the actual pill, patch, or cream you receive — reviewed and approved by the FDA as a specific product, made the same way every time. A compoundedproduct is custom-mixed for you by a pharmacy. Even when it uses a hormone that’s also found in approved drugs, the finished mixture has not been reviewed or approved by the FDA.

FDA-approved estrogen options: pills, patches, gels, sprays, and rings

FDA-approved estrogen comes in several forms — oral pills, skin patches, gels, a spray, vaginal products, and rings. The form matters because systemic forms (pills, patches, gels, spray, and the Femring) treat whole-body symptoms like hot flashes and night sweats, while low-dose vaginal forms treat dryness and painful sex. Estrogen taken through the skin may carry a lower blood-clot and stroke risk than pills, because it skips first-pass processing by the liver.

Pills:Estrace (and generic estradiol), Premarin (conjugated estrogens), Cenestin, and Enjuvia. Note: the FDA recently approved a generic version of Premarin — confirm it’s actually on the shelf at your pharmacy, since “approved” and “launched” aren’t always the same week.

Patches: Climara, Vivelle-Dot, Minivelle, Alora, Dotti, and Menostar (a low-dose patch aimed at bone protection), plus generics. Estradiol patches are generally labeled for hot flashes and night sweats; several also cover vaginal atrophy symptoms and prevention of postmenopausal bone loss. If your onlyissue is vaginal dryness, a low-dose vaginal product is usually the better fit — check the label or ask.

Gels and spray: EstroGel, Divigel, and Elestrin are gels; Evamist is a spray. These are estradiol delivered through the skin, mainly for hot flashes and night sweats.

FDA-approved vaginal (local) estrogen — for dryness and painful sex

FDA-approved vaginal estrogen comes as creams, tablets, inserts, and a low-dose ring, and it treats vaginal dryness, irritation, and painful sex — not hot flashes. Because these products act mostly where you place them, they deliver far less hormone to the rest of your body than systemic HRT. There’s also one FDA-approved non-estrogen vaginal option, prasterone (Intrarosa), for painful sex from menopause dryness.

If dryness, irritation, or pain during sex is your main problem — and hot flashes aren’t — this is likely your category. FDA-approved local options include Estrace vaginal cream and generic estradiol cream, Premarin vaginal cream, the Vagifem and Yuvafem vaginal tablets, the Imvexxy insert, and the Estring low-dose ring. There’s also Intrarosa(prasterone, a form of DHEA) — a vaginal insert that isn’t estrogen but is FDA-approved for painful sex caused by menopause dryness. It’s a local hormone option, not standard whole-body HRT.

Because local estrogen keeps most of the hormone in one place, the “do I need a progestogen?” question works differently than it does for systemic estrogen. Don’t assume the rules are the same — this is a clinician call, and a quick one. See our vaginal estrogen guide for the full breakdown.

Do you need progesterone with estrogen? Why your uterus changes the list

If you have a uterus and take systemic estrogen, you almost always need a progestogen too, to protect the lining of your uterus from overgrowth and reduce the risk of endometrial cancer. FDA-approved progestogen options include micronized progesterone (Prometrium) and medroxyprogesterone (Provera), taken alongside estrogen. If you’ve had a hysterectomy, you usually don’t need a progestogen at all.

Estrogen builds up the lining of your uterus. Left unchecked, that overgrowth raises the risk of endometrial (uterine) cancer. A progestogenkeeps the lining from building up. That’s why women with a uterus who take systemic estrogen get a progestogen too — either as a separate medicine or built into a combination product.

The FDA-approved progestogen add-ons are Prometrium(micronized progesterone — a “bioidentical” progesterone, meaning it matches the progesterone your body makes) and its generics, and Provera (medroxyprogesterone, a synthetic progestin). There’s a real difference between “progesterone” and “progestin,” and your clinician will help you weigh them.

Had a hysterectomy?Then you generally don’t need a progestogen, and estrogen alone may be enough. This is exactly why the list looks different for different women.

FDA-approved combination HRT for women with a uterus

FDA-approved combination products pair estrogen with a progestogen (or, in one case, a SERM) in a single medicine, so women with a uterus can get whole-body symptom relief with uterine protection built in. They come as pills and patches. The right fit depends on your symptoms, route preference, insurance, and health history.

A couple worth calling out. Bijuva combines bioidentical estradiol and bioidentical progesterone in one pill, and it was among the six products the FDA relabeled in February 2026. Climara Pro is a patch combining estradiol and levonorgestrel, labeled for women with a uterus for hot flashes plus prevention of postmenopausal bone loss. And Duaveeis the odd one out — instead of a progestogen, it pairs conjugated estrogens with the SERM bazedoxifene. If a standard progestogen doesn’t sit well with you, it’s worth raising.

Which FDA-approved HRT is for hot flashes vs. dryness vs. bone loss?

The symptom decides the category. Hot flashes and night sweats point to systemic estrogen. Vaginal dryness and painful sex point to local vaginal products. Some systemic products are also labeled to prevent bone loss, but that doesn’t make every HRT prescription a “bone medication.” Matching the product to your main symptom is what keeps you from paying for something that treats the wrong thing.

Is “bioidentical” HRT FDA-approved, or is it compounded?

Some bioidentical hormones are FDA-approved and some are not — the word itself tells you nothing about approval. Estradiol and micronized progesterone are bioidentical ANDFDA-approved (for example, Bijuva and Prometrium). But compounded “bioidentical” creams, capsules, and pellets are custom-mixed by a pharmacy and are NOTFDA-approved, and the FDA has said it doesn’t have evidence they’re safer or more effective than approved products.

“Bioidentical” is a marketing word, not an FDA category. It just means a hormone built to match the ones your body makes. ACOG puts it plainly: bioidentical hormones include FDA-approved products andcompounded preparations that aren’t regulated by the FDA — and compounding pharmacies often use “bioidentical” to implytheir products are more natural, safer, or more effective. That implication isn’t backed by evidence.

Some bioidentical hormones absolutely are FDA-approved. Estradiol, micronized progesterone, and prasterone (DHEA) all appear on the approved list. So you do nothave to choose between “bioidentical” and “FDA-approved” — you can have both. If a bioidentical hormone is what you want, ask for an FDA-approved one.

About estriol specifically:you’ll see “Bi-est” and “Tri-est” creams marketed with estriol. Here’s the fact competitors skip: there are no FDA-approved drugs containing estriol.Every estriol product is compounded. The FDA has said it doesn’t have evidence that estriol is safe and effective or a “safer form of estrogen.”

Translation guide for the language you’ll see in ads

If you came here to find FDA-approved options, you’re already doing the smart thing. The takeaway is simple: a hormone being “bioidentical” does not mean the product is FDA-approved. Ask about the finished product every time. See our full FDA-approved vs. compounded HRT explainer.

Is there an FDA-approved testosterone for women?

No. As of 2026, there is no FDA-approved testosterone product made for womenin the United States. When clinicians use testosterone for menopausal women — most often for low sexual desire — they prescribe an FDA-approved male product off-label at a much lower dose. Testosterone is also a Schedule III controlled substance, so it always requires a prescription and carries extra prescribing rules.

The reality: as of 2020, the FDA had approved 31 testosterone products for men — and none for women, and that hasn’t changed. When a menopause specialist does use testosterone for a woman (usually for low libido that’s genuinely distressing), they’re prescribing a men’sproduct off-label, dosed at roughly one-tenth the male amount. Major groups like The Menopause Society support carefully managed transdermal testosterone for the right patients — but it’s off-label, specialist-managed, and not something to treat casually.

What changed with FDA HRT warning labels in 2025–2026?

In late 2025 the FDA began removing “boxed warning” language about heart disease, breast cancer, and dementia from menopause hormone therapy labels, and on February 12, 2026, it approved the first six relabeled products. The endometrial (uterine) cancer warning stays on estrogen-alone products. Important: this changed the information on the label, not the medicines themselves — they’re still prescription-only, and they still have risks.

Why the change? The FDA pointed to studies showing that women who start hormone therapy within 10 years of menopause (generally before age 60)have a lower risk of death from all causes and fewer fractures. That’s a meaningful update for younger women near the start of menopause.

One note for balance: not everyone was on board with how fast it happened. ACOG had long supported taking another look at these warnings — but it also cautioned that the FDA’s brief expert-panel process wasn’t a substitute for the fuller advisory-committee review usually used for changes this size. The medicines and their real risks didn’t change — only the label did. So don’t read “the FDA removed the warnings” as “HRT has no risks.” Read it as: the FDA decided the old warnings overstated the risk for the women most likely to benefit.

FDA-approved menopause medications that are NOT HRT

Some FDA-approved menopause medicines aren’t hormones at all. For hot flashes, the FDA has approved paroxetine (Brisdelle), fezolinetant (Veozah), and elinzanetant (Lynkuet). For painful sex, it’s approved ospemifene (Osphena). These treat menopause symptoms but are not HRT, so we keep them clearly labeled.

Can online menopause providers prescribe FDA-approved HRT?

Yes — some online menopause providers can prescribe FDA-approved, pharmacy-dispensed HRT when it’s clinically appropriate, but the provider’s model matters. Before you pay, check whether they prescribe FDA-approved products (versus compounded), whether they bill insurance or are cash-pay, which states they serve, and how follow-up care works. Insurance is generally more likely to help with FDA-approved products than compounded ones.

The “what they offer” and pricing columns below are what each provider states on its own site, verified July 2026— we label FDA-approved and compounded separately, but we haven’t re-run every checkout, and prices and terms change, so confirm the current details before you pay.

Already sure you want pharmacy-dispensed, FDA-approved care and want to compare side by side? Compare FDA-approved HRT care paths with verified pricing, insurance, and state availability.

How to check whether your HRT prescription is FDA-approved before you pay

The safest move is to get the exact drug name, generic name, dose, route, and dispensing pharmacy in writing before you pay, then confirm whether it’s an FDA-approved finished drug or a compounded product. Because the same hormone can appear in both, the finished-product question is the one that protects you.

Print these five questions and bring them to any consult — online or in person:

1. What’s the exact brand or generic name?
2. Is this an FDA-approved finished drug, or is it compounded for me?
3. What’s the route — pill, patch, gel, spray, cream, insert, or ring?
4. If I have a uterus, how are you protecting my uterus lining — a separate progestogen, or a combination product?
5. Where does it get filled — my local pharmacy, a mail pharmacy, or a compounding pharmacy? (A compounding pharmacy is your signal it’s a compounded product.)

Two tools you can use yourself

• To confirm it’s FDA-approved, use Drugs@FDA(the FDA’s official database). If the exact product is listed there as approved, it’s an FDA-approved finished drug.
• To read the label details, use DailyMed(dailymed.nlm.nih.gov). DailyMed is great for reading a drug’s current labeling, but it also includes some products that aren’t FDA-approved — so use it for label reading, and use Drugs@FDA to confirm approval status.
• Your pharmacy label and insurance drug listconfirm the exact product and whether it’s covered.

If a provider dodges question #2, that’s your answer. A trustworthy one will tell you straight. Also see our HRT cost guide for what to expect at the pharmacy after you have a prescription.

How we built this list — The HRT Index Verification Standard

We built this page from primary regulatory and label sources first, and providers’ published claims second. The HRT Index Verification Standard is our documented process: read every published detail, separate FDA-approved from compounded, verify availability and coverage, and re-check on a fixed schedule — top providers monthly, the full roster quarterly. It’s a process, not a score, and we don’t invent ratings.

What we actually verified for this page (Last verified: July 2026)

• The FDA categories and the product list — cross-checked against FDA consumer materials, the FDA’s updated-prescribing-information page, and DailyMed
• The February 12, 2026 label changes and the six relabeled products — FDA press release and prescribing-information page
• The October 24, 2025 approval of Lynkuet (elinzanetant) — Bayer and FDA
• Veozah’s December 16, 2024 boxed warning for liver injury — FDA drug safety communication
• That there are no FDA-approved drugs containing estriol, and that compounded “bioidentical” products aren’t FDA-approved — FDA and ACOG
• That there’s no FDA-approved testosterone for women, and that testosterone is a Schedule III controlled substance — ACOG and the DEA
• Midi’s and Winona’s FDA-approved-versus-compounded details, pricing, and coverage — each provider’s own website

Frequently asked questions

What is the most common FDA-approved HRT?

There’s no single “most common” HRT for every woman. FDA-approved options include estradiol pills, patches, gels, and sprays; low-dose vaginal estrogen; progesterone and progestin options; and combination estrogen-progestogen products. The right one depends on your symptoms and whether you have a uterus.

Is estradiol FDA-approved for menopause?

Yes. Many FDA-approved menopause products contain estradiol, including pills (Estrace), patches (Climara, Vivelle-Dot), gels (EstroGel, Divigel), a spray (Evamist), and vaginal forms. But estradiol can also appear in compounded products, so the finished product and pharmacy source still matter.

Is progesterone FDA-approved for HRT?

Yes. Micronized progesterone (Prometrium) is FDA-approved, and it’s often used alongside systemic estrogen for women who have a uterus, to protect the uterus lining. The exact plan should come from your clinician.

Is vaginal estrogen FDA-approved?

Yes. FDA-approved vaginal estrogen options include creams (Estrace, Premarin), tablets (Vagifem, Yuvafem), an insert (Imvexxy), and a low-dose ring (Estring). Don’t confuse the low-dose Estring with the whole-body Femring — they are not the same product.

Is compounded bioidentical HRT FDA-approved?

No. The FDA does not approve compounded drugs and does not review them for safety, effectiveness, or quality before they are sold. A compounded product may use a hormone that is also in FDA-approved drugs, but the finished product itself is not FDA-approved. Some FDA-approved hormones, like estradiol and micronized progesterone, are also bioidentical, so bioidentical does not mean compounded.

Is estriol FDA-approved in the United States?

No. The FDA has stated there are no FDA-approved drugs containing estriol. Any estriol product, including Bi-est and Tri-est creams, is compounded, not FDA-approved.

Is testosterone FDA-approved for menopause symptoms in women?

No. There is no FDA-approved testosterone product for women in the United States. Clinicians sometimes prescribe a men’s testosterone product off-label at a low dose for low libido, but testosterone is a Schedule III controlled substance and should not appear as an FDA-approved HRT for women.

Did the FDA remove the warnings from HRT?

In part. Beginning in late 2025, the FDA started removing boxed-warning language about heart disease, breast cancer, and dementia, approving the first six relabeled products on February 12, 2026. The endometrial (uterine) cancer warning remains on estrogen-alone products, and other risk information stays in the label. The medicines and their risks did not change — the label did.

Are hormone pellets FDA-approved?

No. Hormone pellets are compounded and are not FDA-approved for menopause. The National Academies flagged specific safety concerns with pellets, since the dose cannot be removed once it is implanted. Discuss the risks with an in-person clinician.

Which FDA-approved HRT is best if I have a uterus?

The key isn’t a single brand — it’s making sure your uterus lining is protected. That usually means systemic estrogen plus a progestogen, or a combination product that includes both. Ask your clinician exactly how they are protecting the lining.

Can telehealth prescribe FDA-approved HRT?

Yes. Some telehealth menopause providers prescribe FDA-approved, pharmacy-dispensed HRT when it is appropriate. Verify the exact medication, whether it is compounded, the pharmacy, insurance, your state, and the follow-up plan before you pay.

Does insurance cover FDA-approved HRT?

Often yes — FDA-approved, pharmacy-dispensed medications generally have a clearer insurance path than compounded products, which insurance usually will not cover. It depends on your plan, the exact drug, the pharmacy, any prior-authorization rules, and whether your provider bills insurance at all.

Related reading from The HRT Index

• FDA-approved vs. compounded HRT — plain-English explainer of the regulatory difference
• Which online HRT providers prescribe what — provider-by-form medication map
• Best online HRT providers for menopause — ranked by clinical legitimacy, price transparency, access
• Vaginal estrogen guide — low-dose local estrogen in full detail
• How much does HRT cost in 2026? — real prices by form and provider
• Midi Health review — clinical quality, pricing, and who it fits

Sources

1. FDA. Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms. fda.gov
2. FDA. Menopause: Medicines to Help You. fda.gov
3. FDA. Menopause (Women’s Health Topics) — statements on compounded “bioidentical” hormones and estriol. fda.gov
4. FDA. Human Drug Compounding — compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing. fda.gov
5. FDA. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products (February 12, 2026). fda.gov
6. FDA. Menopausal Hormone Therapies with Updated Prescribing Information (updated February 12, 2026; lists the first six relabeled products). fda.gov
7. FDA / HHS. HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy (November 10, 2025; notes generic Premarin approval). fda.gov
8. FDA. FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant)… (boxed warning update December 16, 2024). fda.gov
9. Bayer. Lynkuet (elinzanetant) Approved in the U.S. for Moderate to Severe Vasomotor Symptoms Due to Menopause (October 24, 2025). bayer.com
10. ACOG. Compounded Bioidentical Menopausal Hormone Therapy (Clinical Consensus, 2023). acog.org
11. National Academies of Sciences, Engineering, and Medicine. Prescribers Should Restrict the Use of Non-FDA-Approved Compounded Bioidentical Hormones, Except for Specific Medical Circumstances (2020). nationalacademies.org
12. U.S. Drug Enforcement Administration. Drug Scheduling (testosterone listed in Schedule III). dea.gov
13. DailyMed (NIH). About DailyMed — includes FDA-approved labeling plus some products that are not FDA-approved. dailymed.nlm.nih.gov
14. Drugs@FDA — FDA database of approved drug products. accessdata.fda.gov/scripts/cder/daf/
15. Midi Health. Insurance-Covered Hormone Replacement Therapy / How Midi Works (verified July 2026). joinmidi.com
16. Winona. Hormone Therapy for Menopause: Benefits, Safety, and Options (verified July 2026). bywinona.com

The HRT Index is an independent decision resource for online menopause and HRT care for women. This page is educational and is not medical advice. FDA-approved and compounded options are always labeled separately here, and compounded products are never presented as equivalent to, safer than, or more natural than FDA-approved medication. Always talk with a licensed clinician about your individual symptoms, history, and risks before starting or changing any treatment. Last verified: July 2026. Find My HRT Path is covered by our consumer health data and privacy policy. See our affiliate disclosure.